Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profusa (PFSA) Common Equity (2023 - 2025)

Profusa filings provide 3 years of Common Equity readings, the most recent being -$26.7 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 77.64% to -$26.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$26.7 million, a 77.64% increase, with the full-year FY2025 number at -$26.7 million, up 77.64% from a year prior.
  • Common Equity hit -$26.7 million in Q4 2025 for Profusa, up from -$34.0 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of -$26.7 million in Q4 2025 to a low of -$124.2 million in Q2 2025.
  • Median Common Equity over the past 3 years was -$114.5 million (2024), compared with a mean of -$97.7 million.
  • The widest YoY moves for Common Equity: up 77.64% in 2025, down 8.79% in 2025.
  • Profusa's Common Equity stood at -$110.0 million in 2023, then dropped by 8.37% to -$119.2 million in 2024, then soared by 77.64% to -$26.7 million in 2025.
  • The last three reported values for Common Equity were -$26.7 million (Q4 2025), -$34.0 million (Q3 2025), and -$124.2 million (Q2 2025) per Business Quant data.